Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1982 Mar;17(3):149-54.

Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension

  • PMID: 7039897
Comparative Study

Comparison of the immediate hemodynamic effects of SQ 14225 (Captopril) and [Sar1, Ileu8] angiotensin II in patients with dialysis resistant hypertension

K Iseki et al. Clin Nephrol. 1982 Mar.

Abstract

The effects of a single dose of 50 mg of SQ 14225 (Captopril) and 0.6 microgram/kg/min infusion of angiotensin II antagonist, [Sar1, Ileu8] (AII-A), were examined in six patients with dialysis resistant hypertension and seven with normal blood pressures. A depressor effect of Captopril was observed even in patients with AII-A unresponsive dialysis resistant hypertension. The fall in mean arterial pressure (MAP) was significantly correlated with the fall in the total peripheral resistance index (TPRI) following both Captopril administration (r = 0.883, P less than 0.01) and AII-A infusion (r = 0.735, P less than 0.01). Basal plasma renin activity (PRA) was the same in patients with dialysis resistant hypertension as in normotensive patients and correlated with the fall in MAP induced by AII-A infusion (r = -0.640, P less than 0.05). It was concluded that the direct effect of the renin-angiotensin system was uncertain in patients with dialysis resistant hypertension and that the depressor effect of Captopril was not secondary to the suppression of angiotensin II formation.

PubMed Disclaimer

Publication types

LinkOut - more resources